Abstract
The study of tissue microbiomes is a recent endeavor in human microbiome research, particularly in the area of blood microbiomes. This is primarily due to their low biomass, which presents inadvertent operational contamination as a significant experimental obstacle. The critical role of the tissue microbiomes in cancer development has brought this topic to the forefront of cancer research. However, a fundamental question regarding the potential biodiversity, as stated in the title, has not been addressed to our knowledge. In this study, we estimate the potential microbial diversity or “dark” biodiversity in human tumor and normal tissues using the Diversify-Area Relationship (DAR) method (Ma 2018, 2019) based on large datasets from TCGA (The Cancer Genome Atlas) database (Poore et al. 2021). We found that the total species richness (number), typical species equivalents (number), and dominant species equivalents (number) of tumor tissues are approximately 1948, 36, and 22, respectively. Among the total species richness, the proportions of archaea, bacteria, and viruses are about 3%-5%, 78%-79%, and 17%-18%, respectively. Moreover, the tissue species richness is approximately 12.5% of skin microbiomes, and 25% of gut microbiomes. We also found that tumor growth does not significantly influence the global or pan-tumor scale diversity, which means that the previous numbers also represent the potential microbial diversity of human tissues, including blood. On a local or single cancer-type scale, tumors may influence the potential diversity in approximately 5% of cases. We hypothesize that, globally, local diversity variations would offset each other.
Lay Summary This study focused on microbiomes - the tiny microbes that live in our tissues, especially blood. Studying them is challenging due to their low biomass and risk of contamination. Microbiomes may play a key role in cancer, but their diversity within tissues remains unclear. Using diversity-area relationship modeling with data from “The Cancer Genome Atlas” database, we estimated the potential microbial diversity of human tumor and normal tissues. We found approximately 1,948 microbial species in tumors, comprising archaea (5%), bacteria (78%) and viruses (17%). However, dominant or common microbial species number only about two to three dozen. Tissue microbe diversity was 12.5% of that found in skin microbiomes and 25% of gut microbiomes. Tumor growth did not significantly impact overall diversity. Therefore, the previous diversity numbers also represent the microbiome diversity of general human tissues and blood. However, some cancer types may affect it locally. While local diversity changes can occur, globally these variations between tissues likely balance out.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
N/A
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
ma{at}vandals.uidaho.edu zhanshanma{at}fas.harvard.edu
Data Availability
Availability of datasets Poore, GD, E Kopylova, Q Zhu, R Knight (2020). Microbiome analyses of blood and tissues suggest cancer diagnostic approach. Nature 579, 567-574. https://doi.org/10.1038/s41586-020-2095-1
Abbreviations
- B
- (Blood Derived Normal)
- DAR-PL
- (DAR Power Law)
- Dmax
- =Maximal Accrual Diversity (MAD)
- DCR
- (Diversity-Cancer Relatinship)
- MAD
- (Maximal Accrual Diversity)
- PT
- (Primary Tumor Tissue)
- SN
- (Solid Normal Tissue)
- DAR
- (Diversity-Area Relationship)
- DAR-PLEC
- (DAR Power Law with Exponential Cutoff)
- DDR
- (Diversity-Disease Relationship)
- LGD
- (Local to Global Diversity Ratio)
- p-DDR,
- p-DCR (popula6on-level DDR/DCR)
